Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ephedrine, ketamine, ondansetron and atropine to prevent nausea and vomiting in spinal anesthesia
IRCT20230713058769N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Sep 2023
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ephedrine, ketamine, ondansetron and atropine in postoperative nausea and vomiting (PONV) (4 arms), sponsored by Arak University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
ephedrineketamineondansetronatropine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20230713058769N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230713058769N1.